1
|
Mateos González M, Sierra Gonzalo E, Casado Lopez I, Arnalich Fernández F, Beato Pérez JL, Monge Monge D, Vargas Núñez JA, García Fenoll R, Suárez Fernández C, Freire Castro SJ, Mendez Bailon M, Perales Fraile I, Madrazo M, Pesqueira Fontan PM, Magallanes Gamboa JO, González García A, Crestelo Vieitez A, Fonseca Aizpuru EM, Aranguren Arostegui A, Coduras Erdozain A, Martinez Cilleros C, Loureiro Amigo J, Epelde F, Lumbreras Bermejo C, Antón Santos JM, for the SEMI-COVID-19-Network. The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals. J Clin Med 2021; 10:305. [PMID: 33467585 PMCID: PMC7830154 DOI: 10.3390/jcm10020305] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2020] [Revised: 12/14/2020] [Accepted: 01/11/2021] [Indexed: 02/06/2023] Open
Abstract
OBJECTIVES A decrease in blood cell counts, especially lymphocytes and eosinophils, has been described in patients with serious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), but there is no knowledge of their potential role of the recovery in these patients' prognosis. This article aims to analyse the effect of blood cell depletion and blood cell recovery on mortality due to COVID-19. DESIGN This work was a retrospective, multicentre cohort study of 9644 hospitalised patients with confirmed COVID-19 from the Spanish Society of Internal Medicine's SEMI-COVID-19 Registry. SETTING This study examined patients hospitalised in 147 hospitals throughout Spain. PARTICIPANTS This work analysed 9644 patients (57.12% male) out of a cohort of 12,826 patients ≥18 years of age hospitalised with COVID-19 in Spain included in the SEMI-COVID-19 Registry as of 29 May 2020. MAIN OUTCOME MEASURES The main outcome measure of this work is the effect of blood cell depletion and blood cell recovery on mortality due to COVID-19. Univariate analysis was performed to determine possible predictors of death, and then multivariate analysis was carried out to control for potential confounders. RESULTS An increase in the eosinophil count on the seventh day of hospitalisation was associated with a better prognosis, including lower mortality rates (5.2% vs. 22.6% in non-recoverers, OR 0.234; 95% CI, 0.154 to 0.354) and lower complication rates, especially regarding the development of acute respiratory distress syndrome (8% vs. 20.1%, p = 0.000) and ICU admission (5.4% vs. 10.8%, p = 0.000). Lymphocyte recovery was found to have no effect on prognosis. Treatment with inhaled or systemic glucocorticoids was not found to be a confounding factor. CONCLUSION Eosinophil recovery in patients with COVID-19 who required hospitalisation had an independent prognostic value for all-cause mortality and a milder course.
Collapse
Affiliation(s)
- María Mateos González
- Internal Medicine Department, Infanta Cristina University Hospital, 28981 Parla, Spain;
| | | | - Irene Casado Lopez
- Internal Medicine Department, Infanta Cristina University Hospital, 28981 Parla, Spain;
| | | | - José Luis Beato Pérez
- Internal Medicine Department, Albacete University Hospital Complex, 02008 Albacete, Spain;
| | - Daniel Monge Monge
- Internal Medicine Department, Segovia Hospital Complex, 40002 Segovia, Spain;
| | | | - Rosa García Fenoll
- Internal Medicine Department, Miguel Servet Hospital, 50009 Zaragoza, Spain;
| | | | | | | | - Isabel Perales Fraile
- Internal Medicine Department, Infanta Sofía Hospital, 28703 San Sebastián de los Reyes, Spain;
| | - Manuel Madrazo
- Internal Medicine Department, Dr. Peset University Hospital, 46017 Valencia, Spain;
| | | | | | | | | | | | | | | | | | - Jose Loureiro Amigo
- Internal Medicine Department, Moisès Broggi Hospital, 08970 Sant Joan Despí, Spain;
| | - Francisco Epelde
- Internal Medicine Department, Parc Tauli Hospital, 08208 Sabadell, Spain;
| | | | | | | |
Collapse
|
2
|
Affiliation(s)
- Lawrence E K Gray
- 1 School of Medicine, Deakin University, Geelong, Victoria, Australia; and
| | - Peter D Sly
- 2 Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia
| |
Collapse
|